< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

3 clusters · 7 sources · 16 days · First seen · Last updated

Turkey GLP-1 weight-loss injection guidance

Overview

In late July 2026, Dr. Ebru Hacer Inal, an internal-medicine specialist, warned that GLP-1 and GIP receptor agonist injections must be initiated and monitored by a physician. While noting these metabolic treatments can improve type-2 diabetes and fatty-liver disease, she emphasized the need for pre-treatment examinations of the gallbladder, pancreas, and eyes, alongside regular blood-test monitoring. She noted that common side effects like nausea and constipation typically subside, but stopping the medication can lead to weight regain.

Following this, nutrition specialist Dyt. Gamze Ustabaş explained that discontinuing these injections triggers a biological appetite rebound, particularly for carbohydrates, as the body attempts to restore lost energy. In a separate discussion, Prof. Dr. Mesut Başak described an alternative method using an abdominal corset to induce satiety, though he warned it is unsuitable for those with reflux or gastritis.

By mid-August, General Surgery Specialist Assoc. Prof. Dr. Sönmez Ocak raised concerns regarding the increasing non-prescription use of second-generation injections. While these drugs can lead to a weight loss of approximately 20 percent, Dr. Ocak warned that the rapid loss of subcutaneous fat can cause facial sagging and an aged appearance. He further cautioned that without sufficient protein and vitamin support, users risk muscle and bone loss, and highlighted potential severe risks including pancreatitis, gallstones, and thyroid cancer.

Entities

Medicana International Samsun Hospital · Gamze Ustabaş · Dr. Ebru Hacer Inal · GLP‑1/GIP receptor agonist injections · Maltepe Ersoy Hospital

Timeline

  1. 17 days ago

    [HEALTH] 2 sources
    Medical expert warns of facial changes from weight loss injections

    Medical expert Assoc. Prof. Dr. Sönmez Ocak warns that weight loss injections can cause facial sagging, muscle loss, and other serious health risks if used without medical supervision.

  2. about 1 month ago

    [HEALTH] 2 sources
    Turkey experts discuss appetite rebound after weight‑loss injections and non‑exercise diet methods

    Turkish experts warn that stopping GLP‑1 weight‑loss injections can trigger strong hunger, and they discuss a non‑exercise corset method that may aid weight loss but has medical cautions.

  3. about 1 month ago

    [HEALTH] 5 sources
    Dr. Ebru Hacer Inal warns against unsupervised weight‑loss injections

    Dr. Ebru Hacer Inal stresses that GLP‑1/GIP weight‑loss injections require doctor supervision, pre‑checks, regular monitoring, may cause early nausea and other side effects, and can lead to weight regain after停

Sources

aksiyon.com.tr · bursahakimiyet.com.tr · guneydoguekspres.com · haber3.com · isca.org.sg · istanbulgazetesi.com.tr · medyagazete.com

This summary has been updated 1 time: see revision history